Eko Foundation Analysis Software with Transformers (EFAST) vs SignalHF
AI Verdict
Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if your primary goal is to enhance the accuracy and efficiency of cardiac screenings during routine physical exams. This tool is ideal for clinicians seeking real-time AI assistance in detecting structural murmurs and atrial fibrillation at the point of care, enabling earlier identification of potential heart conditions.
View Eko Foundation Analysis Software with Transformers (EFAST) →Choose SignalHF if…
Choose SignalHF if you manage a patient population with cardiac implantable electronic devices and aim to proactively reduce heart failure hospitalizations. This solution is best suited for cardiologists who need an FDA-cleared AI algorithm to predict short-term heart failure risk based on CIED data, facilitating timely interventions and personalized care plans.
View SignalHF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | SignalHF |
|---|---|---|
| Pricing | Subscription-based, contact for details | Contact for pricing |
| Deployment | Unknown | SaaS |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)EFAST offers real-time AI analysis during auscultation, enhanced audio, waveform visualization, and guided exams, directly integrating into a clinician's immediate workflow during a patient encounter. This point-of-care application provides a more intuitive and direct user experience compared to SignalHF's data analysis and alert-driven system.
Clinical Value
TieBoth tools provide significant, FDA-cleared clinical value, albeit in different areas of cardiac care. EFAST offers high sensitivity and specificity for real-time detection of structural murmurs and AFib during routine exams, while SignalHF provides crucial predictive analytics for heart failure hospitalizations from CIED data, enabling early intervention.
Pricing & Value
Eko Foundation Analysis Software with Transformers (EFAST)EFAST provides more transparency regarding its pricing model, detailing a subscription-based Eko+ membership, a free trial with stethoscope purchase, and an approximate daily cost for the associated stethoscope technology. In contrast, SignalHF only states 'contact for pricing' with no further details, offering less insight into potential costs.
Enterprise Readiness
SignalHFWhile both are FDA-cleared, HIPAA compliant, and cloud-based, SignalHF explicitly highlights 'manufacturer-agnostic compatibility with various CIEDs' and a 'unified platform for centralizing cardiac implantable device data'. This indicates a stronger capability for integration and management within complex, multi-vendor enterprise healthcare environments.
Innovation
TieBoth tools demonstrate significant innovation. EFAST leverages advanced AI (Transformers) for real-time, point-of-care diagnostics during auscultation, representing a novel approach to early detection. SignalHF innovates with predictive AI for heart failure hospitalizations by analyzing complex CIED data, enabling proactive and personalized patient management.
Support & Docs
Eko Foundation Analysis Software with Transformers (EFAST)Eko Health (Tool A) offers a comprehensive Help Center with user manuals, quick start guides, FAQs, how-to videos, and options to schedule support calls, with documentation available in multiple languages. Implicity (Tool B) mentions 'instructions for use' and 'customer service' but does not detail a public-facing, organized help center or extensive documentation resources comparable to Eko Health's offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | SignalHF |
|---|---|---|
| Product Name | Eko Foundation Analysis Software with Transformers (EFAST) | SignalHF |
| Company | Eko Health | Implicity |
| Primary AI Function | Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. | Predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care. |
| Target Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
| Key Capabilities | AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation; Enhanced audio with noise cancellation and amplification; Waveform visualization and guided exams. | FDA-cleared AI algorithm for heart failure prediction; Predicts heart failure hospitalizations within 30 days; Generates automatic alerts for care teams based on risk scores; AI-driven alert management to filter and highlight relevant events. |
| Data Source/Integration | Seamless integration with Eko digital stethoscopes (e.g., CORE 500); Cloud-based recording and secure storage of exams; EMR integration. | Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs); Analyzes physiological data, demographics, lead measurements, episodes, and therapies; Unified platform for centralizing cardiac implantable device data. |
Videos
Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and SignalHF.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or SignalHF
Backers
Who funded each tool's parent company.